Latest News in the pharma Industry

Top Stories

Bayer set to buy Schiff Nutrition International for $1.2bn

Bayer set to buy Schiff Nutrition International for $1.2bn

30 Oct 2012

Bayer has struck a deal to acquire US vitamin maker Schiff.

Read more 
BioRx receives Zemaira distribution rights

BioRx receives Zemaira distribution rights

30 Oct 2012

BioRx has been added to the distribution network for Zemaira.

Read more 
Celgene reports $1.4 billion of revenues for third quarter 2012

Celgene reports $1.4 billion of revenues for third quarter 2012

26 Oct 2012

Celgene enjoyed healthy profits in the third quarter of 2012

Read more 
Sanofi to continue developing Prednisporin under sub-licencing agreement

Sanofi to continue developing Prednisporin under sub-licencing agreement

26 Oct 2012

Sanofi will continue development of Prednisporin, but expects to sub-licence the work to a third-party.

Read more 
Organisational structure 'key to pharma compliance'

Organisational structure 'key to pharma compliance'

26 Oct 2012

Pharmaceuticals have been told to centralise their compliance efforts for greater success.

Read more 
Report reveals downward trend in US health R&D investment

Report reveals downward trend in US health R&D investment

26 Oct 2012

There are concerns that the downward trend in R&D investment in the US could jeopardise the country's global competitiveness.

Read more 
Charles River enters strategic partnership with AstraZeneca

Charles River enters strategic partnership with AstraZeneca

25 Oct 2012

Charles River Laboratories and AstraZeneca have reached a three-year agreement to deliver toxicology, safety pharmacology and development DMPK studies.

Read more 
Forest and moksha8 form broad strategic alliance for Latin America

Forest and moksha8 form broad strategic alliance for Latin America

25 Oct 2012

Forest Laboratories and moksha8 have announced a broad strategic alliance for Latin America.

Read more 
Medicated chewing gum may prevent motion sickness

Medicated chewing gum may prevent motion sickness

22 Oct 2012

A team in Iran have produced a prototype gum with an acceptable taste that could help to deliver the motion sickness drug dimenhydrinate more rapidly.

Read more 
'Slight decline' in pharmaceutical M&A activity

'Slight decline' in pharmaceutical M&A activity

22 Oct 2012

A new report has highlighted a slight downward trend in mergers and acquisitions.

Read more 
Global autologous cell therapy market worth $2.2bn by 2017

Global autologous cell therapy market worth $2.2bn by 2017

16 Oct 2012

A number of autologous cell therapies are expected to reach the market by 2017, fuelling an impressive growth rate over the next few years.

Read more 
Patent expiries 'pose challenge to enzyme inhibitor market growth'

Patent expiries 'pose challenge to enzyme inhibitor market growth'

16 Oct 2012

A new TechNavio report has looked at the state of the global enzyme inhibitor market and its prospects for growth

Read more